"The greatest wealth is health."         - Virgil

      Advertisement

Our Experts answered these questions:

My wife has arthritis,quite severe. if she sustains a bruise or a cut the results last for weeks or even months. she bruises badly with the slightest...
I was up last night having to use the bathroom with diarrhea for about an hour. This morning i woke up and i felt like i was going to throw up and i h...
Do You Have a Health Question? Ask Our Experts!

Vaccine Safety

Menu

• Home
• Ask our Experts about CANCIDAS
• Ask Community about CANCIDAS
• Read More Here
• Patients Wiki
• Share Your Health Story
• Take a Survey
• Health Blogs

More Resources

• Federal Food and Drug Administration
• Hospital Quality Reports
• Home Care Quality

CANCIDAS Safety Questions, CANCIDAS Answers

More Here>>Side Effects - FDA Reports 2006-2008

Medications A-Z:   A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Welcome! Patientsville.com provides unique information about CANCIDAS. Our extensive database of CANCIDAS adverse events and CANCIDAS warnings is updated regularly. If you have questions, you can post them to one of our health experts or ask others in our broad patient community.

>> Announcements

Check out our Hospital and Home Care Quality Reports.

Ask Our Health Experts about CANCIDAS

Do You Have a Question about Your Health?

Our Doctors and Nurses will Help You Understand Your Symptoms and Feel Better!
Private, Confidential and Discreet

Type your question here

 letters left

CANCIDAS Safety Reports

Total CANCIDAS reports: 162.
CANCIDAS FDA safety alerts: No.
Reported deaths: 87    Reported hospitalizations: 69.
Take CANCIDAS Side Effects Survey or Share Your CANCIDAS Story. Read More Here.

Showing 1-75 of 162 Next >

Physician from MALAYSIA reported CANCIDAS problem on May 24, 2006. Male patient, 15 years of age, weighting 110.2 lb, was diagnosed with fungal infection and was treated with CANCIDAS. After drug was administered, patient experienced the following problems/side effects: prescribed overdose, sepsis. CANCIDAS dosage: unknown. Patient died on 05/23/2006.

CANCIDAS problem was reported by a Physician from MALAYSIA on May 24, 2006. Male patient, 15 years of age, weighting 110.2 lb, was diagnosed with fungal infection and was treated with CANCIDAS. After drug was administered, patient experienced the following problems/side effects: acute myeloid leukaemia, condition aggravated, prescribed overdose, sepsis. CANCIDAS dosage: unknown. Patient died on 05/23/2006.

Physician from DENMARK reported CANCIDAS problem on Mar 27, 2006. Female patient, 66 years of age, was diagnosed with fungal sepsis and was treated with CANCIDAS. After drug was administered, patient experienced the following problems/side effects: hepatic necrosis, multi-organ failure, shock. CANCIDAS dosage: unknown. During the same period patient was treated with AMPHOTERICIN B, VORICONAZOLE, CEFUROXIME, TOBRAMYCIN. Patient was hospitalized. Patient died.

CANCIDAS problem was reported by a Physician from CHINA on Mar 29, 2006. Male patient, 51 years of age, was diagnosed with sepsis, lung infection and was treated with CANCIDAS. After drug was administered, patient experienced the following problems/side effects: blood lactate dehydrogenase increased, blood urea increased, face oedema, flushing, hepatic failure, oedema peripheral, oliguria, rash. CANCIDAS dosage: unknown. During the same period patient was treated with AMPHOTERICIN B, AMPHOTERICIN B, CILASTATIN AND IMIPENEM, CILASTATIN AND IMIPENEM. Patient died on 04/01/2006.

Pharmacist from FRANCE reported CANCIDAS problem on June 09, 2006. Male patient, 53 years of age, was diagnosed with systemic candida, liver transplant, diabetes mellitus, pain, hypertension, infection and was treated with CANCIDAS. After drug was administered, patient experienced the following problems/side effects: pancytopenia, pneumocystis jiroveci pneumonia. CANCIDAS dosage: unknown. During the same period patient was treated with TACROLIMUS, INSULIN, MORPHINE, NICARDIPINE HYDROCHLORIDE, CIPROFLOXACIN HYDROCHLORIDE. Patient was hospitalized. Patient recovered.

CANCIDAS problem was reported by a Physician from SPAIN on July 10, 2006. Male patient, 68 years of age, was diagnosed with systemic candida and was treated with CANCIDAS. After drug was administered, patient experienced the following problems/side effects: anaemia, cholestasis, hepatotoxicity, platelet count decreased, pyrexia, white blood cell count decreased. CANCIDAS dosage: unknown. During the same period patient was treated with AMIODARONE HYDROCHLORIDE, DIPYRONE, SPIRONOLACTONE, DALTEPARIN, PROPOFOL, NOREPINEPHRINE HYDROCHLORIDE, TEICOPLANIN. Patient recovered.

Physician from DENMARK reported CANCIDAS problem on Mar 27, 2006. Female patient, 66 years of age, was diagnosed with fungal sepsis and was treated with CANCIDAS. After drug was administered, patient experienced the following problems/side effects: hepatic necrosis, multi-organ failure, shock. CANCIDAS dosage: unknown. During the same period patient was treated with AMPHOTERICIN B, VORICONAZOLE, CEFUROXIME, TOBRAMYCIN. Patient was hospitalized. Patient died.

CANCIDAS problem was reported by a Pharmacist from AUSTRALIA on Apr 04, 2006. Male patient, 61 years of age, was diagnosed with diabetes mellitus, hypertension, prophylaxis, hypercholesterolaemia and was treated with CANCIDAS. After drug was administered, patient experienced the following problems/side effects: hyperkalaemia. CANCIDAS dosage: unknown. During the same period patient was treated with METFORMIN, RAMIPRIL, OMEPRAZOLE, FOLIC ACID, SULFAMETHOXAZOLE AND TRIMETHOPRIM, ATORVASTATIN CALCIUM, GLIMEPIRIDE, RITUXIMAB. Patient recovered.

Physician from SPAIN reported CANCIDAS problem on July 10, 2006. Male patient, 68 years of age, was diagnosed with systemic candida, supraventricular tachycardia, hyperthermia, hypokalaemia, polyuria, thrombosis prophylaxis, sedation, hypotension and was treated with CANCIDAS. After drug was administered, patient experienced the following problems/side effects: anaemia, anisocytosis, cholestasis, eosinophil count increased, hepatotoxicity, hypochromasia, macrocytosis, platelet count decreased, pyrexia. CANCIDAS dosage: unknown. During the same period patient was treated with AMIODARONE HYDROCHLORIDE, DIPYRONE, SPIRONOLACTONE, DALTEPARIN, PROPOFOL, NOREPINEPHRINE HYDROCHLORIDE. Patient recovered.

CANCIDAS problem was reported by a Health Professional from PORTUGAL on Aug 07, 2006. Female patient, 46 years of age, was diagnosed with bronchopulmonary aspergillosis and was treated with CANCIDAS. After drug was administered, patient experienced the following problems/side effects: hepatic failure, hepatic necrosis, septic shock. CANCIDAS dosage: 50 MG/DAILY IV. During the same period patient was treated with CYTARABINE, PIPERACILLIN AND TAZOBACTAM, AMIKACIN, ACETAMINOPHEN. Patient recovered.

Consumer or non-health professional from GERMANY reported CANCIDAS problem on Aug 04, 2006. Male patient, 76 years of age, was treated with CANCIDAS. After drug was administered, patient experienced the following problems/side effects: disease progression. CANCIDAS dosage: 50 MG/DAILY IV. Patient died.

CANCIDAS problem was reported by a Pharmacist from UNITED STATES on Aug 29, 2006. Female patient, 85 years of age, was diagnosed with candidiasis and was treated with CANCIDAS. After drug was administered, patient experienced the following problems/side effects: hepatic failure. CANCIDAS dosage: unknown. During the same period patient was treated with AMIODARONA, FLUCONAZOLE, LEVOTHYROXINE, ACETAMINOPHEN, DILANTIN. Patient recovered.

Consumer or non-health professional from BRAZIL reported CANCIDAS problem on Aug 28, 2006. Female patient, 54 years of age, was diagnosed with systemic candida and was treated with CANCIDAS. After drug was administered, patient experienced the following problems/side effects: abdominal tenderness, acute respiratory distress syndrome, bowel sounds abnormal, respiratory failure, septic shock. CANCIDAS dosage: unknown. Patient died.

CANCIDAS problem was reported by a Consumer or non-health professional from FRANCE on Aug 18, 2006. Male patient, 67 years of age, was diagnosed with systemic candida and was treated with CANCIDAS. After drug was administered, patient experienced the following problems/side effects: aspergillosis, cellulitis, disease progression, systemic candida. CANCIDAS dosage: unknown. During the same period patient was treated with AMIKACIN SULPHATE, AMOXICILLIN, AMPHOTERICIN B, ASPIRIN, BISOPROLOL FUMARATE, CASPOFUNGIN ACETATE, DIGOXIN. Patient was hospitalized. Patient died.

Pharmacist from UNITED STATES reported CANCIDAS problem on Aug 29, 2006. Female patient, 85 years of age, was diagnosed with candidiasis and was treated with CANCIDAS. After drug was administered, patient experienced the following problems/side effects: cardiac failure, hepatic failure, sepsis. CANCIDAS dosage: unknown. During the same period patient was treated with AMIODARONA, FLUCONAZOLE, LEVOTHYROXINE, ACETAMINOPHEN, DILANTIN. Patient died on 08/29/2006.

CANCIDAS problem was reported by a Consumer or non-health professional from FRANCE on Aug 18, 2006. Male patient, 67 years of age, was diagnosed with systemic candida and was treated with CANCIDAS. After drug was administered, patient experienced the following problems/side effects: cellulitis, disease progression, sepsis, systemic candida. CANCIDAS dosage: unknown. During the same period patient was treated with AMIKACIN SULPHATE, AMOXICILLIN, AMPHOTERICIN B, ASPIRIN, BISOPROLOL FUMARATE, CASPOFUNGIN ACETATE, DIGOXIN. Patient was hospitalized. Patient died.

Physician from FRANCE reported CANCIDAS problem on Sept 13, 2006. Male patient, 65 years of age, was diagnosed with systemic candida and was treated with CANCIDAS. After drug was administered, patient experienced the following problems/side effects: blood calcium decreased, blood sodium decreased, renal tubular disorder. CANCIDAS dosage: unknown. During the same period patient was treated with PIPERACILLIN AND TAZOBACTAM, MIDAZOLAM HYDROCHLORIDE, FUROSEMIDE, HYDROCORTISONE HEMISUCCINATE. Patient recovered.

CANCIDAS problem was reported by a Physician from FRANCE on Sept 05, 2006. Male patient, 67 years of age, was diagnosed with systemic candida and was treated with CANCIDAS. After drug was administered, patient experienced the following problems/side effects: arteriosclerosis, aspergillosis, bronchopneumopathy, cardiomyopathy, cellulitis, disease recurrence, hepatic steatosis, hepatomegaly, pericardial effusion. CANCIDAS dosage: unknown. During the same period patient was treated with AMIKACIN SULPHATE, AMOXICILLIN, AMPHOTERICIN B, ASPIRIN, BISOPROLOL FUMARATE, CASPOFUNGIN ACETATE, DIGOXIN. Patient was hospitalized. Patient died.

Physician from SPAIN reported CANCIDAS problem on Sept 13, 2006. Female patient, 42 years of age, was diagnosed with sepsis and was treated with CANCIDAS. After drug was administered, patient experienced the following problems/side effects: convulsion. CANCIDAS dosage: unknown. During the same period patient was treated with AMPHOTERICIN B AND CHOLESTEROL AND DISTEAROYLPHOSPHATIDYLGLYCEROL AND, MEROPENEM. Patient recovered.

CANCIDAS problem was reported by a Physician from AUSTRIA on Sept 18, 2006. Male patient, 45 years of age, was diagnosed with candidiasis and was treated with CANCIDAS. After drug was administered, patient experienced the following problems/side effects: aspergillosis. CANCIDAS dosage: unknown. During the same period patient was treated with FLUCONAZOLE. Patient was hospitalized. Patient recovered.

Physician from FRANCE reported CANCIDAS problem on Sept 13, 2006. Male patient, 65 years of age, was diagnosed with systemic candida and was treated with CANCIDAS. After drug was administered, patient experienced the following problems/side effects: renal tubular disorder. CANCIDAS dosage: unknown. During the same period patient was treated with PIPERACILLIN AND TAZOBACTAM, MIDAZOLAM HYDROCHLORIDE, FUROSEMIDE, HYDROCORTISONE HEMISUCCINATE, ESOMEPRAZOLE MAGNESIUM, CLOPIDOGREL BISULPHATE, ENOXAPARIN. Patient recovered.

CANCIDAS problem was reported by a Consumer or non-health professional from BELGIUM on Sept 08, 2006. Male patient, 65 years of age, was diagnosed with systemic candida and was treated with CANCIDAS. After drug was administered, patient experienced the following problems/side effects: pneumonia necrotising, respiratory arrest, respiratory failure. CANCIDAS dosage: unknown. Patient died.

Physician from GERMANY reported CANCIDAS problem on Sept 22, 2006. Male patient, 27 years of age, was diagnosed with systemic candida, acute myeloid leukaemia, prophylaxis and was treated with CANCIDAS. After drug was administered, patient experienced the following problems/side effects: prescribed overdose. CANCIDAS dosage: unknown. During the same period patient was treated with CYTARABINE, MITOXANTRONE HYDROCHLORIDE, AMPHOTERICIN B, CEFTRIAXONE, GENTAMICIN, PIPERACILLIN AND TAZOBACTAM. Patient was hospitalized. Patient recovered.

CANCIDAS problem was reported by a Physician from AUSTRIA on Sept 18, 2006. Male patient, 45 years of age, was diagnosed with candidiasis and was treated with CANCIDAS. After drug was administered, patient experienced the following problems/side effects: aspergillosis. CANCIDAS dosage: unknown. During the same period patient was treated with FLUCONAZOLE. Patient was hospitalized. Patient recovered.

Physician from PANAMA reported CANCIDAS problem on Sept 11, 2006. Female patient was diagnosed with candidiasis and was treated with CANCIDAS. After drug was administered, patient experienced the following problems/side effects: hypotension. CANCIDAS dosage: 2.2 MG/DAILY INJ. During the same period patient was treated with AMPHOTERICIN B, BUMETANIDE, CIPROFLOXACIN, DOPAMINE, FLUCONAZOLE, FUROSEMIDE, MEROPENEM. Patient recovered.

CANCIDAS problem was reported by a Pharmacist from UNITED STATES on Sept 29, 2006. Female patient, 61 years of age, was diagnosed with fungal infection and was treated with CANCIDAS. After drug was administered, patient experienced the following problems/side effects: arrhythmia, blood calcium decreased, electrocardiogram qt prolonged, hypokalaemia, hypomagnesaemia, torsade de pointes. CANCIDAS dosage: unknown. During the same period patient was treated with MOXIFLOXACIN HYDROCHLORIDE. Patient was hospitalized. Patient recovered.

Physician from BELGIUM reported CANCIDAS problem on Sept 08, 2006. Male patient, 65 years of age, was diagnosed with systemic candida and was treated with CANCIDAS. After drug was administered, patient experienced the following problems/side effects: chills, pneumonia necrotising, respiratory failure. CANCIDAS dosage: unknown. Patient died.

CANCIDAS problem was reported by a Physician from FRANCE on Sept 13, 2006. Male patient, 65 years of age, was diagnosed with systemic candida and was treated with CANCIDAS. After drug was administered, patient experienced the following problems/side effects: infection, renal tubular disorder. CANCIDAS dosage: unknown. During the same period patient was treated with PIPERACILLIN AND TAZOBACTAM, MIDAZOLAM HYDROCHLORIDE, FUROSEMIDE, HYDROCORTISONE HEMISUCCINATE, ESOMEPRAZOLE MAGNESIUM, CLOPIDOGREL BISULPHATE, ENOXAPARIN. Patient recovered.

Consumer or non-health professional from PANAMA reported CANCIDAS problem on Sept 25, 2006. Female patient was diagnosed with candidiasis, sepsis and was treated with CANCIDAS. After drug was administered, patient experienced the following problems/side effects: decreased activity, haematocrit decreased, haemoglobin decreased, hypotension, pallor, sepsis. CANCIDAS dosage: unknown. During the same period patient was treated with AMIKACIN, AMPHOTERICIN B, BUMETANIDE, CIPROFLOXACIN, DOPAMINE HCI, FLUCONAZOLE, FUROSEMIDE, MEROPENEM. Patient recovered.

CANCIDAS problem was reported by a Physician from BELGIUM on Oct 11, 2006. Female patient, 38 years of age, was diagnosed with aspergillosis and was treated with CANCIDAS. After drug was administered, patient experienced the following problems/side effects: no therapeutic response. CANCIDAS dosage: unknown. Patient died.

Physician from SPAIN reported CANCIDAS problem on Sept 13, 2006. Female patient, 42 years of age, was diagnosed with sepsis, blood culture positive and was treated with CANCIDAS. After drug was administered, patient experienced the following problems/side effects: convulsion. CANCIDAS dosage: unknown. During the same period patient was treated with DISTEAROYLPHOSPHATIDYLGLYCEROL AND AMPHOTERICIN B AND CHOLESTEROL AND, AMPHOTERICIN B AND CHOLESTEROL AND DISTEAROYLPHOSPHATIDYLGLYCEROL AND, MEROPENEM. Patient recovered.

CANCIDAS problem was reported by a Consumer or non-health professional from PANAMA on Oct 03, 2006. Female patient was diagnosed with candidiasis, sepsis and was treated with CANCIDAS. After drug was administered, patient experienced the following problems/side effects: acinetobacter infection, decreased activity, haematocrit decreased, haemoglobin decreased, hypotension, pallor, sepsis. CANCIDAS dosage: 2.2 MG/DAILY, INJ. During the same period patient was treated with AMIKACIN, AMPHOTERICIN B, CIPROFLOXACIN, DOPAMINE, FLUCONAZOLE, FUROSEMIDE, HYDRALAZINE, MEROPENEM. Patient recovered.

Physician from SPAIN reported CANCIDAS problem on Sept 13, 2006. Female patient, 42 years of age, was diagnosed with sepsis, blood culture positive and was treated with CANCIDAS. After drug was administered, patient experienced the following problems/side effects: hormone level abnormal, metabolic disorder, status epilepticus. CANCIDAS dosage: unknown. During the same period patient was treated with AMPHOTERICIN B AND CHOLESTEROL AND DISTEAROYLPHOSPHATIDYLGLYCEROL AND, AMPHOTERICIN B AND CHOLESTEROL AND DISTEAROYLPHOSPHATIDYLGLYCEROL AND, MEROPENEM. Patient recovered.

CANCIDAS problem was reported by a Physician from ITALY on Oct 17, 2006. Male patient, 59 years of age, was diagnosed with aspergillosis and was treated with CANCIDAS. After drug was administered, patient experienced the following problems/side effects: dyspnoea, fungal infection. CANCIDAS dosage: unknown. During the same period patient was treated with VORICONAZOLE. Patient died.

Physician from UNITED STATES reported CANCIDAS problem on Oct 19, 2006. Female patient, 36 years of age, was diagnosed with vaginal candidiasis and was treated with CANCIDAS. After drug was administered, patient experienced the following problems/side effects: vaginal candidiasis. CANCIDAS dosage: unknown. During the same period patient was treated with ANIDULAFUNGIN. Patient was hospitalized. Patient recovered.

CANCIDAS problem was reported by a Physician from UNITED KINGDOM on Oct 17, 2006. Male patient, 71 years of age, was treated with CANCIDAS. After drug was administered, patient experienced the following problems/side effects: multi-organ failure, systemic inflammatory response syndrome. CANCIDAS dosage: unknown. Patient died.

Physician from UNITED STATES reported CANCIDAS problem on Aug 29, 2006. Female patient, 85 years of age, was diagnosed with candidiasis and was treated with CANCIDAS. After drug was administered, patient experienced the following problems/side effects: multi-organ failure. CANCIDAS dosage: unknown. During the same period patient was treated with AMIODARONA, FLUCONAZOLE, LEVOTHYROXINE, ACETAMINOPHEN, DILANTIN, VANCOMYCIN, LASIX, PROTONIX. Patient was hospitalized. Patient died on 08/30/2006.

CANCIDAS problem was reported by a Physician from UNITED STATES on Oct 19, 2006. Female patient, 36 years of age, was diagnosed with vaginal candidiasis and was treated with CANCIDAS. After drug was administered, patient experienced the following problems/side effects: vaginal candidiasis. CANCIDAS dosage: unknown. During the same period patient was treated with ANIDULAFUNGIN. Patient was hospitalized. Patient recovered.

Pharmacist from UNITED STATES reported CANCIDAS problem on Nov 10, 2006. Male patient, 73 years of age, was diagnosed with urinary tract infection fungal and was treated with CANCIDAS. After drug was administered, patient experienced the following problems/side effects: angioneurotic oedema. CANCIDAS dosage: unknown. Patient recovered.

CANCIDAS problem was reported by a Physician from UNITED ARAB EMIRATES on Nov 09, 2006. Male patient, 47 years of age, was diagnosed with septic shock, acute myeloid leukaemia and was treated with CANCIDAS. After drug was administered, patient experienced the following problems/side effects: blood potassium increased, candidiasis, metastases to skin, multi-organ failure. CANCIDAS dosage: unknown. During the same period patient was treated with AMPHOTERICIN B. Patient was hospitalized. Patient died.

Physician from FRANCE reported CANCIDAS problem on Sept 13, 2006. Male patient, 58 years of age, was diagnosed with systemic candida and was treated with CANCIDAS. After drug was administered, patient experienced the following problems/side effects: renal tubular disorder. CANCIDAS dosage: unknown. During the same period patient was treated with PIPERACILLIN AND TAZOBACTAM, MIDAZOLAM HYDROCHLORIDE, FUROSEMIDE, HYDROCORTISONE HEMISUCCINATE, ESOMEPRAZOLE MAGNESIUM, CLOPIDOGREL BISULPHATE, ENOXAPARIN. Patient recovered.

CANCIDAS problem was reported by a Physician from UNITED ARAB EMIRATES on Nov 09, 2006. Female patient, 34 years of age, was diagnosed with septic shock, acute lymphocytic leukaemia and was treated with CANCIDAS. After drug was administered, patient experienced the following problems/side effects: bacteraemia, candidiasis, chills, multi-organ failure. CANCIDAS dosage: unknown. During the same period patient was treated with AMPHOTERICIN B, AMPHOTERICIN B. Patient was hospitalized. Patient died.

Physician from UNITED STATES reported CANCIDAS problem on Nov 15, 2006. Female patient, 50 years of age, was treated with CANCIDAS. After drug was administered, patient experienced the following problems/side effects: hepatic failure. CANCIDAS dosage: unknown. Patient recovered.

CANCIDAS problem was reported by a Health Professional from FRANCE on Nov 20, 2006. Female patient, 56 years of age, weighting 83.78 lb, was diagnosed with systemic candida and was treated with CANCIDAS. After drug was administered, patient experienced the following problems/side effects: hepatitis. CANCIDAS dosage: unknown. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from GERMANY reported CANCIDAS problem on Nov 03, 2006. Male patient, 76 years of age, was treated with CANCIDAS. After drug was administered, patient experienced the following problems/side effects: acute myeloid leukaemia. CANCIDAS dosage: 50 MG/DAILY IV. During the same period patient was treated with CODEINE PHOSPHATE, PANTOPRAZOLE, RAMIPRIL, TORSEMIDE. Patient recovered.

CANCIDAS problem was reported by a Health Professional from FRANCE on Nov 20, 2006. Female patient, 56 years of age, weighting 83.78 lb, was diagnosed with systemic candida and was treated with CANCIDAS. After drug was administered, patient experienced the following problems/side effects: hepatitis. CANCIDAS dosage: unknown. Patient was hospitalized. Patient recovered.

Health Professional from FRANCE reported CANCIDAS problem on Nov 20, 2006. Female patient, 56 years of age, weighting 83.78 lb, was diagnosed with systemic candida and was treated with CANCIDAS. After drug was administered, patient experienced the following problems/side effects: hepatitis. CANCIDAS dosage: unknown. Patient was hospitalized. Patient recovered.

CANCIDAS problem was reported by a Physician from BELGIUM on Oct 11, 2006. Female patient, 38 years of age, was diagnosed with aspergillosis and was treated with CANCIDAS. After drug was administered, patient experienced the following problems/side effects: no therapeutic response. CANCIDAS dosage: unknown. Patient died on 10/09/2006.

Physician from UNITED KINGDOM reported CANCIDAS problem on Sept 14, 2006. Female patient, 71 years of age, weighting 154.3 lb, was diagnosed with pyonephrosis, diabetes mellitus and was treated with CANCIDAS. After drug was administered, patient experienced the following problems/side effects: blood culture positive, candida sepsis, culture urine positive, disease recurrence, ureteric stenosis, urosepsis. CANCIDAS dosage: unknown. During the same period patient was treated with AMPHOTERICIN B, INSULIN. Patient was hospitalized. Patient recovered.

CANCIDAS problem was reported by a Pharmacist from IRELAND on Sept 18, 2006. Male patient, 31 years of age, weighting 156.5 lb, was diagnosed with sepsis, hypertension, endocarditis, agitation, coagulopathy, thrombocytopenia, prophylaxis of nausea and vomiting and was treated with CANCIDAS. After drug was administered, patient experienced the following problems/side effects: atrioventricular block, cardiac arrest. CANCIDAS dosage: unknown. During the same period patient was treated with AMLODIPINE BESYLATE, PENICILLIN G, CLONIDINE, DESMOPRESSIN, ESOMEPRAZOLE, FOLINIC ACID, METOCLOPRAMIDE. Patient was hospitalized. Patient recovered.

Physician from FRANCE reported CANCIDAS problem on Dec 19, 2006. Female patient, 49 years of age, was diagnosed with bronchopulmonary aspergillosis, liver transplant and was treated with CANCIDAS. After drug was administered, patient experienced the following problems/side effects: cytomegalovirus colitis. CANCIDAS dosage: unknown. Patient was hospitalized. Patient recovered.

CANCIDAS problem was reported by a Physician from SPAIN on Dec 15, 2006. Female patient, 70 years of age, was diagnosed with systemic candida and was treated with CANCIDAS. After drug was administered, patient experienced the following problems/side effects: cholestasis. CANCIDAS dosage: 50 MG/DAILY IV. During the same period patient was treated with AMINO ACIDS, CARBOHYDRATES, FLUCONAZOLE, MEROPENEM, OMEPRAZOLE. Patient recovered.

Physician from CANADA reported CANCIDAS problem on June 21, 2007. Male patient, 70 years of age, was diagnosed with fungal infection, acute myeloid leukaemia and was treated with CANCIDAS. After drug was administered, patient experienced the following problems/side effects: condition aggravated, fungaemia, fungal infection, localised infection. CANCIDAS dosage: unknown. During the same period patient was treated with VORICONAZOLE, MITOXANTRONE HYDROCHLORIDE, ETOPOSIDE, CYTARABINE. Patient was hospitalized. Patient died.

CANCIDAS problem was reported by a Physician from KOREA, REPUBLIC OF on June 28, 2007. Male patient, 61 years of age, weighting 147.7 lb, was diagnosed with aspergillosis, pneumonia, gastritis prophylaxis, dyspepsia and was treated with CANCIDAS. After drug was administered, patient experienced the following problems/side effects: septic shock. CANCIDAS dosage: unknown. During the same period patient was treated with PIPERACILLIN AND TAZOBACTAM, PIPERACILLIN AND TAZOBACTAM, AMPHOTERICIN B, LEVOFLOXACIN, DEXAMETHASONE, RANITIDINE, SIMETHICONE. Patient died on 06/17/2007.

Physician from AUSTRIA reported CANCIDAS problem on June 26, 2007. Male patient, 67 years of age, was diagnosed with candidiasis and was treated with CANCIDAS. After drug was administered, patient experienced the following problems/side effects: hepatic infection fungal, immune system disorder, intestinal functional disorder, ulcer. CANCIDAS dosage: unknown. During the same period patient was treated with VORICONAZOLE, AVELOX. Patient was hospitalized. Patient died on 04/20/2007.

CANCIDAS problem was reported by a Physician from CANADA on June 21, 2007. Male patient, 70 years of age, was diagnosed with fungal infection, acute myeloid leukaemia and was treated with CANCIDAS. After drug was administered, patient experienced the following problems/side effects: condition aggravated, fungaemia, fungal infection, localised infection. CANCIDAS dosage: unknown. During the same period patient was treated with VORICONAZOLE, MITOXANTRONE HYDROCHLORIDE, ETOPOSIDE, CYTARABINE. Patient was hospitalized. Patient died.

Physician from TURKEY reported CANCIDAS problem on June 26, 2007. Female patient, 15 years of age, was treated with CANCIDAS. CANCIDAS dosage: unknown. During the same period patient was treated with AMPHOTERICIN B, AMPHOTERICIN B, AMPHOTERICIN B, ITRACONAZOLE. Patient was hospitalized. Patient died.

CANCIDAS problem was reported by a Physician from AUSTRIA on July 05, 2007. Female patient, 49 years of age, weighting 99.21 lb, was diagnosed with aspergillosis and was treated with CANCIDAS. After drug was administered, patient experienced the following problems/side effects: septic shock, systemic mycosis. CANCIDAS dosage: unknown. During the same period patient was treated with VORICONAZOLE, PIPERACILLIN AND TAZOBACTAM, VANCOMYCIN, FLUCONAZOLE, MEROPENEM, CIPROFLOXACIN. Patient was hospitalized. Patient died on 05/01/2006.

Physician from FRANCE reported CANCIDAS problem on July 11, 2007. Male patient, 72 years of age, was diagnosed with candida pneumonia, urinary tract infection, depression, anxiety and was treated with CANCIDAS. After drug was administered, patient experienced the following problems/side effects: anuria, renal failure acute. CANCIDAS dosage: unknown. Patient died on 06/22/2007.

CANCIDAS problem was reported by a Health Professional from UNITED STATES on July 18, 2007. Female patient, 40 years of age, weighting 229.3 lb, was diagnosed with fungal infection, enterobacter infection and was treated with CANCIDAS. After drug was administered, patient experienced the following problems/side effects: toxic epidermal necrolysis. CANCIDAS dosage: unknown. During the same period patient was treated with ZOSYN. Patient died.

Physician from UNITED STATES reported CANCIDAS problem on July 19, 2007. Male patient, 40 years of age, was treated with CANCIDAS. After drug was administered, patient experienced the following problems/side effects: renal failure acute. CANCIDAS dosage: unknown. During the same period patient was treated with ZOSYN. Patient was hospitalized and became disabled. Patient died.

CANCIDAS problem was reported by a Health Professional from FRANCE on July 16, 2007. Male patient, 17 years of age, was diagnosed with bronchopulmonary aspergillosis, acute myeloid leukaemia, hyperthermia and was treated with CANCIDAS. After drug was administered, patient experienced the following problems/side effects: arrhythmia, cardio-respiratory arrest, cerebellar syndrome. CANCIDAS dosage: unknown. During the same period patient was treated with CILASTATIN AND IMIPENEM, CYTARABINE, AMSACRINE, PIPERACILLIN AND TAZOBACTAM, AMIKACIN SULPHATE. Patient died on 06/10/2007.

Physician from GERMANY reported CANCIDAS problem on July 12, 2007. Female patient, 55 years of age, was diagnosed with bronchopulmonary aspergillosis, graft versus host disease and was treated with CANCIDAS. After drug was administered, patient experienced the following problems/side effects: bronchopulmonary aspergillosis, respiratory failure. CANCIDAS dosage: unknown. During the same period patient was treated with MYCOPHENOLATE MOFETIL, CORTISONE. Patient died.

CANCIDAS problem was reported by a Physician from BRAZIL on June 04, 2007. Female patient, 75 years of age, was diagnosed with device related infection, septic embolus and was treated with CANCIDAS. After drug was administered, patient experienced the following problems/side effects: device related infection, hepatitis, septic embolus. CANCIDAS dosage: unknown. During the same period patient was treated with TARGOCID, POLYMYXIN B SULPHATE, HEPARIN, MAREVAN, PROPOFOL, FENTANYL, DORMONIDECTION. Patient died on 05/23/2007.

Physician from FRANCE reported CANCIDAS problem on July 20, 2007. Male patient, 18 years of age, was diagnosed with antifungal prophylaxis and was treated with CANCIDAS. After drug was administered, patient experienced the following problems/side effects: delayed engraftment, multi-organ failure, systemic candida. CANCIDAS dosage: unknown. During the same period patient was treated with VORICONAZOLE. Patient was hospitalized. Patient died.

CANCIDAS problem was reported by a Physician from FRANCE on July 20, 2007. Male patient, 32 years of age, was diagnosed with antifungal prophylaxis and was treated with CANCIDAS. After drug was administered, patient experienced the following problems/side effects: bronchopulmonary aspergillosis, graft versus host disease, respiratory failure, systemic candida. CANCIDAS dosage: unknown. During the same period patient was treated with FLUCONAZOLE. Patient was hospitalized. Patient died.

Physician from FRANCE reported CANCIDAS problem on July 20, 2007. Male patient, 46 years of age, was diagnosed with antifungal prophylaxis and was treated with CANCIDAS. After drug was administered, patient experienced the following problems/side effects: acute graft versus host disease, cytomegalovirus infection, respiratory failure, systemic candida. CANCIDAS dosage: unknown. During the same period patient was treated with FLUCONAZOLE. Patient was hospitalized. Patient died.

CANCIDAS problem was reported by a Physician from MEXICO on July 30, 2007. Male patient, 60 years of age, weighting 176.4 lb, was diagnosed with respiratory moniliasis, urinary tract infection fungal, renal failure, prophylaxis against gastrointestinal ulcer, pneumonia, analgesia, abdominal pain and was treated with CANCIDAS. After drug was administered, patient experienced the following problems/side effects: jaundice. CANCIDAS dosage: unknown. During the same period patient was treated with FUROSEMIDE, OMEPRAZOLE, CEFTRIAXONE, AMIKACIN, CLONIXIN LYSINE, BUTILHIOSCINA, NIMESULIDE. Patient recovered.

Health Professional from GERMANY reported CANCIDAS problem on July 30, 2007. Male patient, 25 years of age, weighting 178.6 lb, was diagnosed with pneumonia primary atypical, fungal infection and was treated with CANCIDAS. After drug was administered, patient experienced the following problems/side effects: blood bilirubin increased, respiratory failure, sepsis. CANCIDAS dosage: unknown. During the same period patient was treated with SEMPERA, KLACID. Patient died on 07/22/2005.

CANCIDAS problem was reported by a Physician from KUWAIT on July 26, 2007. Male patient, weighting 6.61 lb, was diagnosed with candidiasis and was treated with CANCIDAS. After drug was administered, patient experienced the following problems/side effects: candidiasis. CANCIDAS dosage: unknown. During the same period patient was treated with AMPHOTERICIN B AND CHOLESTEROL AND DISTEAROYLPHOSPHATIDYLGLYCEROL AND, FLUCONAZOLE. Patient died.

Physician from THAILAND reported CANCIDAS problem on July 23, 2007. Male patient, 21 years of age, was diagnosed with fungal infection and was treated with CANCIDAS. After drug was administered, patient experienced the following problems/side effects: cerebral haemorrhage. CANCIDAS dosage: unknown. During the same period patient was treated with AMPHOTERICIN B AND CHOLESTEROL AND DISTEAROYLPHOSPHATIDYLGLYCEROL AND. Patient recovered.

CANCIDAS problem was reported by a Physician from ITALY on Aug 03, 2007. Female patient, child 7 years of age, was diagnosed with bronchopulmonary aspergillosis and was treated with CANCIDAS. After drug was administered, patient experienced the following problems/side effects: acute graft versus host disease, acute myeloid leukaemia, bronchopulmonary aspergillosis, chronic graft versus host disease, hyperglycaemia, metabolic encephalopathy. CANCIDAS dosage: unknown. During the same period patient was treated with AMPHOTERICIN B. Patient died.

Physician from CHINA reported CANCIDAS problem on Aug 06, 2007. Male patient, 80 years of age, was diagnosed with fungal infection, cerebral infarction and was treated with CANCIDAS. After drug was administered, patient experienced the following problems/side effects: haemoptysis, pneumonia. CANCIDAS dosage: unknown. During the same period patient was treated with TIENAM, ALPROSTADIL. Patient died on 07/04/2007.

CANCIDAS problem was reported by a Health Professional from FRANCE on Aug 13, 2007. Male patient, 16 years of age, was diagnosed with bronchopulmonary aspergillosis, acute myeloid leukaemia, hyperthermia and was treated with CANCIDAS. After drug was administered, patient experienced the following problems/side effects: arrhythmia, cardio-respiratory arrest, cerebellar syndrome. CANCIDAS dosage: unknown. During the same period patient was treated with CILASTATIN AND IMIPENEM, CYTARABINE, AMSACRINE, PIPERACILLIN AND TAZOBACTAM, AMIKACIN SULPHATE. Patient died on 06/10/2007.

Consumer or non-health professional from AUSTRIA reported CANCIDAS problem on Aug 14, 2007. Male patient, 39 years of age, was diagnosed with brain abscess and was treated with CANCIDAS. After drug was administered, patient experienced the following problems/side effects: multi-organ failure. CANCIDAS dosage: unknown. During the same period patient was treated with FOSFOMYCIN, VANCOMYCIN, METRONIDAZOLE, CATECHOLAMINE, VORICONAZOLE. Patient died.

Showing 1-75 of 162 Next >

Ask Our Patient Community about CANCIDAS
Select a Medication and Click to Access Reports about Side Effects and Adverse Reactions
A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z
This drug has an active FDA Safety Alert
A Abacavir sulfate Abatacept Abilify Acamprosate calcium Accupril Accutane Aceon Aciphex Actiq (fentanyl citrate) Actimmune (aripiprazole) (quinapril) (isotretinoin) (perindopril) (rabeprazole) (interferon gamma-1b) Actonel (risedronate) Actoplus Met (pioglitazone) Actos (pioglitazone) AcuTect (technetium Tc 99m apcitide) Adefovir dipivoxil Advair Diskus(Fluticasone propionate; Salmeterol xinafoate) Adderall (amphetamine salts) Agenerase (amprenavir) Aggrastat (tirofiban) Alamast (pemirolast) Alendronate Alemtuzumab Aleve (naproxen sodium) Alfuzosin Alinia (nitazoxanide) Alimta (pemetrexed) Alitretinoin Almotriptan malate Alosetron hydrochloride Aloxi (palonosetron) Alrex (loteprednol etabonate) Altace (ramipril) Ambien (zolpidem tartrate) Amerge (naratriptan) Aminolevulinic acid Amiodarone Amitiza (lubiprostone) Amnesteem (isotretinoin) Amphadase (hyaluronidase) luronidase) Amphetamine salts Amprenavir Anaprox (naproxen sodium) Angiomax (bivalirudin) Anidulafungin Antagon (ganirelix acetate) Anthelios SX (avobenzone, ecamsule, octocrylene) Apidra (insulin glulisine recombinant) Apokyn (apomorphine) Aprepitant Aprotinin Aptivus (tipranavir) Aranesp (darbepoetin alpha) Arava (leflunomide) Arformoterol Argatroban Aredia (pamidronate) Aripiprazole Arixtra (fondaparinux) Aromasin (exemestane) Arranon (nelarabine) Arsenic trioxide Aspirin Atacand (candesartan cilexetil) Atazanavir sulfate Atomoxetine Avastin (bevacizumab) Avelox (moxifloxacin) Avobenzone, Ecamsule, Octocrylene Avodart (dutasteride) Avonex (interferon beta-1a) Axert (almotriptan malate) Azacitidine Azilect (rasagiline) Azopt (brinzolamide) back to top B Balsalazide disodium Baraclude (entecavir) Benazepril Benicar (olmesartan medoxomil) Bevacizumab Bexarotene Bextra (valdecoxib) Biaxin (clarithromycin) Bimatoprost Bivalirudin Boniva (ibandronate) Bortezomib Brinzolamide Brovana (arformoterol) Bupropion Butisol sodium Byetta (exenatide) back to top C Calfactant Campath (alemtuzumab) Campral (acamprosate calcium) Cancidas (caspofungin) Candesartan cilexetil Capecitabine Capoten (captopril) Captopril Carbamazepine Carbatrol (carbamazepine) Carbrital (pentobarbital and carbromal) Caspofungin Cefditoren pivoxil Cefepime Ceftriaxone Celebrex (celecoxib) Celecoxib Celexa (citalopram hydrobromide) Cetrorelix acetate Cetrotide (cetrorelix acetate) Cetuximab Cevimeline Chantix (varenicline) Cialis (tadalafil) Cilostazol Cinacalcet Cirlesonide Citalopram Claravis (isotretinoin) Clarithromycin Clarinex (desloratadine) Clolar (clofarabine) Clofarabine Clozapine Clozaril (clozapine) Codeine Colazal (balsalazide disodium) Colesevelam Colistimethate Coly-Mycin M (colistimethate) Comtan (entacapone) Concerta (methylphenidate) Conivaptan Cordarone (amiodarone) Crestor (rosuvastatin calcium) Cubicin (daptomycin) Curosurf (poractant alfa) Cylert (pemoline) Cymbalta (duloxetine) Cytotec (misoprostol) back to top D Dacogen (decitabine) Dalfopristin Dalmane (flurazepam) Daptomycin Darbepoetin alpha Darifenacin Darunavir Dasatinib Daytrana (methylphenidate transdermal) DDAVP (desmopressin) DDAVP Nasal Spray (demopressin) DDAVP Rhinal Tube (desmopressin) DDVP (desmopressin Decitabine Deferasirox Definity (perflutren lipid microspheres) Depacon (valproate) Depakene (valproate) Depakote (valproate) Desloratadine Desmopressin Detrol (tolterodine tartrate) terodine tartrate) Dexedrine (dextroamphetamine sulfate) Dexmedetomidine Dexmethylphenidate HCl > Dextroamphetamine sulfate Diastat AcuDial Diazepam rectal gel Didronel (etidronate) Diprivan (propofol) Dofetilide Doral (quazepam) Doxercalcif Drospirenone Duloxetine Duragesic (fentanyl transdermal system) Dutasteride back to top E Eculizumab Edetate disodium Efalizumab Efavirenz Effexor (venlafaxine) Elestat (epinastine) Eletriptan Elidel (pimecrolimus) Ellence (epirubicin) Eloxatin (oxaliplatin) Emend (aprepitant) Emtricitabine Emtriva (emtricitabine) Enablex (darifenacin) Enalapril / Enalaprilat Endrate (edetate disodium) Enfuvirtide Entacapone Entecavir Epinastine Epirubicin Eplerenone Epoetin alfa Epogen (epoetin alfa) Eptifibatide Equetro (carbamazepine) Eraxis (anidulafungin) Erbitux (cetuximab) Ertaczo (sertaconazole) Escitalopram Estazolam Eszopiclone Ethchlorvynol Ethinyl estradiol Etidronate Evoxac (cevimeline) Exelon (rivastigmine tartrate) Exenatide Exjade (deferasirox) Exemestane Extraneal (icodextrin) Ezetimibe Ezetimibe/simvastatin back to top	F Factive (gemifloxacin mesylate) Faslodex (fulvestrant) Felbamate Felbatol (felbamate) Fentanyl buccal tablets Fentanyl citrate Fentanyl transdermal system Fentora (fentanyl buccal tablets) Ferrlecit (sodium ferric gluconate complex) Fleet Accu-Prep (sodium phosphate) Fleet Phospho-Soda (sodium phosphate) Fluoxetine Flurazepam Fluticasone propionate Fluvoxamine Focalin (dexmethylphenidate) Focalin XR (dexmethylphenidate) Fomivirsen Fondaparinux Foradil (formoterol fumarate) Formoterol fumarate Fosamax (alendronate) Fosinopril Frova (frovatriptan succinate) Frovatriptan succinate Fulvestrant Fuzeon (enfuvirtide) G Gabapentin Gabitril (tiagabine) Gadobenate Dimeglumine Gadodiamide Gadolinium Gadopentetate Dimeglumine Gadoteridol Gadoversetamide Galantamine Ganirelix acetate Gatifloxacin Gefitinib Gemifloxacin mesylate Gemtuzumab ozogamicin Geodon (ziprasidone) Gleevec (imatinib mesylate) back to top H Halcion (triazolam) Haldol (haloperidol) Haloperidol Hectorol (doxercalcif) Hepsera (adefovir dipivoxil) Hyaluronidase Hydase (hyaluronidase) Human Secretin back to top I Ibandronate Ibuprofen Icodextrin Iloprost Imatinib mesylate Increlex (Mecasermin [rDNA origin] Infasurf Preservative Free (calfactant) Imitrex (sumatriptan) Innohep (tinzaparin) Inspra (eplerenone) Insulin Aspart recombinant Insulin Detemir recombinant Insulin Glargine recombinant Insulin Glulisine recombinant Intron A (interferon alfa-2b) Integrilin (eptifibatide) ifibatide) Interferon alfa-2b Interferon beta-1a Interferon gamma-1b Invega (paliperidone) Iplex  (mecasermin rinfabate) Iressa (gefitinib) Isotretinoin back to top J Januvia (sitagliptin phosphate) back to top K Kaletra (lopinavir; ritonavir) Kepivance (palifermin) Keppra (levetiracetam) Ketek (telithromycin) Ketotifen fumarate back to top L Lamictal (lamotrigine) Lamotrigine Lantus (insulin glargine recombinant) Leflunomide Lenalidomide Lepirudin recombinant Levalbuterol Levemir (insulin detemir recombinant) Levetiracetam Levitra (vardenafil) Levonorgestrel Levothyroxine sodium Levulan Kerastick (aminolevulinic acid) Lexapro (escitalopram) Lindane Linezolid Lisinopril Lopinavir/ritonavir Lotemax (loteprednol etabonate) Lotensin (benazepril) Loteprednol etabonate Lotronex (alosetron hydrochloride) Lubiprostone Lucentis (ranibizumab) Lumigan (bimatoprost) Lunestra (eszopiclone) Lyrica (pregabalin) back to top M Macugen (pegaptanib) Magnevist (gadopentetate dimeglumine) Maraviroc Mavik (trandolapril) Maxalt (rizatriptan benzoate) Maxipime (cefepime) Mecasermin [rDNA origin] Mecasermin-rinfabate Meloxicam Memantine Metadate CD (methylphenidate HCl) ylphenidate HCl) Methylphenidate HCl Methylphenidate transdermal Mequinol Micafungin Micardis (telmisartan) misartan) Mifeprex (mifepristone) Mifepristone Miglustat Minirin (desmopressin) Mirtazapine Misoprostol Mobic (meloxicam) Modafinil Moexipril Monopril (fosinopril) Moxifloxacin MultiHance (gadobenate dimeglumine) Mycamine (micafungin) Mylotarg (gemtuzumab ozogamicin) back to top N Namenda (memantine) Naprosyn (naproxen) Naproxen Naratriptan Nesiritide recombinant Nateglinide Natrecor (nesiritide recombinant) Nefazodone Nelarabine NeoTect Kit (technetium Tc 99m depreotide) Nesiritide recombinant Neurontin (gabapentin) Nexavar (sorafenib) Nitazoxanide Nitisinone Norelgestromin NovoLog (insulin aspart recombinant) Noxafil (posaconazole) back to top O Olanzapine Olanzapine/fluoxetine Olmesartan medoxomil Omacor (omega-3-acid ethyl esters) Omalizumab Omega-3-acid ethyl esters Omnaris (cirlesonide)